The role of lymphatics in renal inflammation

Nephrology Dialysis Transplantation

Volumn 27, Issue 7, 2012, Pages 2634-2641

  Seeger, Harald ^a   Bonani, Marco ^a   Segerer, Stephan ^a,b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

lymphatic endothelial cells; lymphatic vessels; renal allograft; renal inflammation; tubulointerstitial inflammation

Indexed keywords

CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR7; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 5; PODOPLANIN; SPHINGOSINE 1 PHOSPHATE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 3;

CAUSAL ATTRIBUTION; CELL INFILTRATION; CELL MIGRATION; CELL MOTION; DENDRITIC CELL; HISTOPATHOLOGY; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; INFLAMMATION; INTERSTITIAL NEPHRITIS; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; LYMPH VESSEL; LYMPHANGIOGENESIS; MACROPHAGE; MULTIPLE MYELOMA; NEPHRITIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; REVIEW; T LYMPHOCYTE;

ANIMALS; HUMANS; INFLAMMATION; KIDNEY DISEASES; LYMPHATIC SYSTEM;

EID: 84864402285     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs140     Document Type: Review

References (82)

1. Földi MFöldi's Textbook of Lymphology for Physicians and Lymphedema Therapists. 2nd edn. Munich, Germany: Elsevier, 2006.
2. Leonhardt H. Taschenatlas der Anatomie. Innere Organe. Stuttgart, Germany: Georg Thieme Verlag, 1991.
3. Wang Y, Oliver G. Current views on the function of the lymphatic vasculature in health and disease. Genes Dev 2010; 24: 2115-2126.
4. Alitalo K. The lymphatic vasculature in disease. Nat Med 2011; 17: 1371-1380.
5. Castenholz A. Functional microanatomy of initial lymphatics with special consideration of the extracellular matrix. Lymphology 1998; 31: 101-118.
6. Baluk P, Fuxe J, Hashizume H et al. Functionally specialized junctions between endothelial cells of lymphatic vessels. J Exp Med 2007; 204: 2349-2362.
7. Tammela T, Saaristo A, Holopainen T et al. Therapeutic differentiation and maturation of lymphatic vessels after lymph node dissection and transplantation. Nat Med 2007; 13: 1458-1466.
8. Solito R, Alessandrini C, Fruschelli M et al. An immunological correlation between the anchoring filaments of initial lymph vessels and the neighboring elastic fibers: a unified morphofunctional concept. Lymphology 1997; 30: 194-202.
9. Tammela T, Alitalo K. Lymphangiogenesis: molecular mechanisms and future promise. Cell 2010; 140: 460-476.
10. Florey H. Observations on the contractility of lacteals: Part I. J Physiol 1927; 62: 267-272.
11. Wick N, Saharinen P, Saharinen J et al. Transcriptomal comparison of human dermal lymphatic endothelial cells ex vivo and in vitro. Physiol Genomics 2007; 28: 179-192.
12. Podgrabinska S, Braun P, Velasco P et al. Molecular characterization of lymphatic endothelial cells. Proc Natl Acad Sci USA 2002; 99: 16069-16074.
13. Breiteneder-Geleff S, Matsui K, Soleiman A et al. Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis. Am J Pathol 1997; 151: 1141-1152.
14. Weninger W, Partanen TA, Breiteneder-Geleff S et al. Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells. Lab Invest 1999; 79: 243-251.
15. Banerji S, Ni J, Wang SX et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 1999; 144: 789-801.
16. Wigle JT, Oliver G. Prox1 function is required for the development of the murine lymphatic system. Cell 1999; 98: 769-778.
17. Kawai Y, Hosaka K, Kaidoh M et al. Heterogeneity in immunohistochemical, genomic, and biological properties of human lymphatic endothelial cells between initial and collecting lymph vessels. Lymphat Res Biol 2008; 6: 15-27.
18. Schulte-Merker S, Sabine A, Petrova TV. Lymphatic vascular morphogenesis in development, physiology, and disease. J Cell Biol 2011; 193: 607-618.
19. Tammela T, Enholm B, Alitalo K et al. The biology of vascular endothelial growth factors. Cardiovasc Res 2005; 65: 550-563.
20. Schacht V, Ramirez MI, Hong YK et al. T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. EMBO J 2003; 22: 3546-3556.
21. Alexander JS, Chaitanya GV, Grisham MB et al. Emerging roles of lymphatics in inflammatory bowel disease. Ann N Y Acad Sci 2010; 1207Suppl 1E75-E85.
22. Kataru RP, Jung K, Jang C et al. Critical role of CD11b+ macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution. Blood 2009; 113: 5650-5659.
23. Huggenberger R, Ullmann S, Proulx ST et al. Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation. J Exp Med 2010; 207: 2255-2269.
24. Machnik A, Dahlmann A, Kopp C et al. Mononuclear phagocyte system depletion blocks interstitial tonicity-responsive enhancer binding protein/vascular endothelial growth factor C expression and induces salt-sensitive hypertension in rats. Hypertension 2010; 55: 755-761.
25. Alitalo K, Tammela T, Petrova TV. Lymphangiogenesis in development and human disease. Nature 2005; 438: 946-953.
26. Baluk P, Tammela T, Ator E et al. Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J Clin Invest 2005; 115: 247-257.
27. Cursiefen C, Chen L, Borges LP et al. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest 2004; 113: 1040-1050.
28. Yao LC, Baluk P, Feng J et al. Steroid-resistant lymphatic remodeling in chronically inflamed mouse airways. Am J Pathol 2010; 176: 1525-1541.
29. Ristimaki A, Narko K, Enholm B et al. Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C. J Biol Chem 1998; 273: 8413-8418.
30. Flister MJ, Wilber A, Hall KL et al. Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NFkappaB and Prox1. Blood 2010; 115: 418-429.
31. Mounzer RH, Svendsen OS, Baluk P et al. Lymphotoxin-alpha contributes to lymphangiogenesis. Blood 2010; 116: 2173-2182.
32. Kerjaschki D, Huttary N, Raab I et al. Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants. Nat Med 2006; 12: 230-234.
33. Maruyama K, Ii M, Cursiefen C et al. Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J Clin Invest 2005; 115: 2363-2372.
34. Machnik A, Neuhofer W, Jantsch J et al. Macrophages regulate saltdependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism. Nat Med 2009; 15: 545-552.
35. Albuquerque RJ, Hayashi T, Cho WG et al. Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth. Nat Med 2009; 15: 1023-1030.
36. Mackay CR, Marston WL, Dudler L. Naive and memory T cells show distinct pathways of lymphocyte recirculation. J Exp Med 1990; 171: 801-817.
37. Itano AA, McSorley SJ, Reinhardt RL et al. Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity. Immunity 2003; 19: 47-57.
38. Roozendaal R, Mebius RE, Kraal G. The conduit system of the lymph node. Int Immunol 2008; 20: 1483-1487.
39. de la Torre YM, Locati M, Buracchi C et al. Increased inflammation in mice deficient for the chemokine decoy receptor D6. Eur J Immunol 2005; 35: 1342-1346.
40. Segerer S, Jedlicka J, Wuthrich RP. Atypical chemokine receptors in renal inflammation. Nephron Exp Nephrol 2010; 115: e89-e95.
41. Wick N, Haluza D, Gurnhofer E et al. Lymphatic precollectors contain a novel, specialized subpopulation of podoplanin low, CCL27-expressing lymphatic endothelial cells. Am J Pathol 2008; 173: 1202-1209.
42. Pruenster M, Mudde L, Bombosi P et al. The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity. Nat Immunol 2009; 10: 101-108.
43. Forster R, Davalos-Misslitz AC, Rot A. CCR7 and its ligands: balancing immunity and tolerance. Nat Rev Immunol 2008; 8: 362-371.
44. Johnson LA, Jackson DG. Inflammation-induced secretion of CCL21 in lymphatic endothelium is a key regulator of integrinmediated dendritic cell transmigration. Int Immunol 2010; 22: 839-849.
45. Kriehuber E, Breiteneder-Geleff S, Groeger M et al. Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages. J Exp Med 2001; 194: 797-808.
46. Pflicke H, Sixt M. Preformed portals facilitate dendritic cell entry into afferent lymphatic vessels. J Exp Med 2009; 206: 2925-2935.
47. Bromley SK, Thomas SY, Luster AD. Chemokine receptor CCR7 guides T cell exit from peripheral tissues and entry into afferent lymphatics. Nat Immunol 2005; 6: 895-901.
48. Debes GF, Arnold CN, Young AJ et al. Chemokine receptor CCR7 required for T lymphocyte exit from peripheral tissues. Nat Immunol 2005; 6: 889-894.
49. Kabashima K, Shiraishi N, Sugita K et al. CXCL12-CXCR4 engagement is required for migration of cutaneous dendritic cells. Am J Pathol 2007; 171: 1249-1257.
50. Ledgerwood LG, Lal G, Zhang N et al. The sphingosine 1-phosphate receptor 1 causes tissue retention by inhibiting the entry of peripheral tissue T lymphocytes into afferent lymphatics. Nat Immunol 2008; 9: 42-53.
51. Thangada S, Khanna KM, Blaho VA et al. Cell-surface residence of sphingosine 1-phosphate receptor 1 on lymphocytes determines lymphocyte egress kinetics. J Exp Med 2010; 207: 1475-1483.
52. Johnson LA, Jackson DG. Cell traffic and the lymphatic endothelium. Ann N Y Acad Sci 2008; 1131: 119-133.
53. Cera MR, Del Prete A, Vecchi A et al. Increased DC trafficking to lymph nodes and contact hypersensitivity in junctional adhesion molecule-A-deficient mice. J Clin Invest 2004; 114: 729-738.
54. Albertine KH, O'Morchoe CC. An integrated light and electron microscopic study on the existence of intramedullary lymphatics in the dog kidney. Lymphology 1980; 13: 100-106.
55. Kriz W. Lymphatic vessels of mammalian kidneys. Verh Anat Ges 1969; 63: 25-32.
56. McIntosh GH, Morris B. The lymphatics of the kidney and the formation of renal lymph. J Physiol 1971; 214: 365-376.
57. Peirce EC, 2nd. Renal lymphatics. Anat Ree 1944; 90: 315-335.
58. Lee HW, Qin YX, Kim YM et al. Expression of lymphatic endothelium-specific hyaluronan receptor LYVE-1 in the developing mouse kidney. Cell Tissue Res 2011; 343: 429-444.
59. Sakamoto I, Ito Y, Mizuno M et al. Lymphatic vessels develop during tubulointerstitial fibrosis. Kidney Int 2009; 75: 828-838.
60. Heller F, Lindenmeyer MT, Cohen CD et al. The contribution of B cells to renal interstitial inflammation. Am J Pathol 2007; 170: 457-468.
61. Kalof AN, Cooper K. D2-40 immunohistochemistry-so far!. Adv Anat Pathol 2009; 16: 62-64.
62. Neusser MA, Kraus AK, Regele H et al. The chemokine receptor CXCR7 is expressed on lymphatic endothelial cells during renal allograft rejection. Kidney Int 2010; 77: 801-808.
63. Pusztaszeri MP, Seelentag W, Bosman FT. Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues. J Histochem Cytochem 2006; 54: 385-395.
64. Kukk E, Lymboussaki A, Taira S et al. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development 1996; 122: 3829-3837.
65. Bonsib SM. Renal lymphatics, and lymphatic involvement in sinus vein invasive (pT3b) clear cell renal cell carcinoma: a study of 40 cases. Mod Pathol 2006; 19: 746-753.
66. Ishikawa Y, Akasaka Y, Kiguchi H et al. The human renal lymphatics under normal and pathological conditions. Histopathology 2006; 49: 265-273.
67. Zhang T, Guan G, Liu G et al. Disturbance of lymph circulation develops renal fibrosis in rats with or without contralateral nephrectomy. Nephrology (Carlton) 2008; 13: 128-138.
68. Jedlicka J, Soleiman A, Draganovici D et al. Interstitial inflammation in Alport syndrome. Hum Pathol 2010; 41: 582-593.
69. Segerer S, Banas B, Wornle M et al. CXCR3 is involved in tubulointerstitial injury in human glomerulonephritis. Am J Pathol 2004; 164: 635-649.
70. Matsui K, Nagy-Bojarsky K, Laakkonen P et al. Lymphatic microvessels in the rat remnant kidney model of renal fibrosis: aminopeptidase p and podoplanin are discriminatory markers for endothelial cells of blood and lymphatic vessels. J Am Soc Nephrol 2003; 14: 1981-1989.
71. Suzuki Y, Ito Y, Mizuno M et al. Transforming growth factor-beta induces vascular endothelial growth factor-C expression leading to lymphangiogenesis in rat unilateral ureteral obstruction. Kidney Int 2012
72. Zimmer JK, Dahdal S, Muhlfeld C et al. Lymphangiogenesis is upregulated in kidneys of patients with multiple myeloma. Anat Rec (Hoboken) 2010; 293: 1497-1505.
73. Mobley JE, O'Dell RM. The role of lymphatics in renal transplantation. Renal lymphatic regeneration. J Surg Res 1967; 7: 231-233.
74. Murray JE, Lang S, Miller BF et al. Prolonged functional survival of renal autotransplants in the dog. Surg Gynecol Obstet 1956; 103: 15-22.
75. Malek P, Vrubel J, Kolc J. Lymphatic aspects of experimental and clinical renal transplantation. Bull Soc Int Chir 1969; 28: 110-114.
76. Pedersen NC, Morris B. The role of the lymphatic system in the rejection of homografts: a study of lymph from renal transplants. J Exp Med 1970; 131: 936-969.
77. Kerjaschki D, Regele HM, Moosberger I et al. Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J Am Soc Nephrol 2004; 15: 603-612.
78. Stuht S, Gwinner W, Franz I et al. Lymphatic neoangiogenesis in human renal allografts: results from sequential protocol biopsies. Am J Transplant 2007; 7: 377-384.
79. Segerer S, Heller F, Lindenmeyer MT et al. Compartment specific expression of dendritic cell markers in human glomerulonephritis. Kidney Int 2008; 74: 37-46.
80. Adair A, Mitchell DR, Kipari T et al. Peritubular capillary rarefaction and lymphangiogenesis in chronic allograft failure. Transplantation 2007; 83: 1542-1550.
81. Kerjaschki D. The crucial role of macrophages in lymphangiogenesis. J Clin Invest 2005; 115: 2316-2319.
82. Yin N, Zhang N, Xu J et al. Targeting lymphangiogenesis after islet transplantation prolongs islet allograft survival. Transplantation 2011; 92: 25-30.